PolyPeptide Group AG (PPGN.SW)
PolyPeptide Group AG is a contract development and manufacturing company specializing in synthetic peptides and oligonucleotides for pharmaceutical and biotech companies globally. They offer a diverse portfolio of peptide-based therapies for various medical applications.
Company Info
Highlights
CHF 730.59M
-CHF 0.82
CHF 15.48 - CHF 35.80
CHF 36.21
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of CHF 10,000 in PolyPeptide Group AG, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
PolyPeptide Group AG had a return of -22.54% year-to-date (YTD) and 36.48% in the last 12 months.
PPGN.SW
-22.54%
-17.29%
-33.63%
36.48%
N/A
N/A
^GSPC (Benchmark)
2.90%
3.70%
10.94%
22.18%
12.41%
11.21%
Monthly Returns
The table below presents the monthly returns of PPGN.SW, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | -9.68% | -22.54% | |||||||||||
| 2024 | -9.53% | 1.58% | 88.20% | 0.00% | 10.23% | -14.37% | 2.80% | 15.31% | -10.03% | -5.57% | 0.52% | -1.90% | 62.10% |
| 2023 | 4.42% | -3.03% | -27.81% | 21.02% | 5.00% | -20.20% | 9.22% | 21.95% | -33.12% | 1.79% | 8.81% | -5.40% | -30.81% |
| 2022 | -32.85% | -11.63% | -9.59% | 17.42% | -12.44% | -13.41% | -30.98% | -20.00% | -19.44% | 0.41% | 18.41% | -26.57% | -81.45% |
| 2021 | 27.95% | -5.74% | 12.90% | 15.69% | 34.41% | -9.34% | -2.99% | 7.71% | 8.90% | 118.44% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of PPGN.SW is 70, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for PolyPeptide Group AG (PPGN.SW) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
PolyPeptide Group AG provided a 0.00% dividend yield over the last twelve months, with an annual payout of CHF 0.00 per share.
| Period | TTM | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Dividend | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 0.30 |
Dividend yield | 0.00% | 0.00% | 0.00% | 1.18% |
Monthly Dividends
The table displays the monthly dividend distributions for PolyPeptide Group AG. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | CHF 0.00 | CHF 0.00 | CHF 0.00 | ||||||||||
| 2024 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 0.00 |
| 2023 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 0.00 |
| 2022 | CHF 0.30 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 0.00 | CHF 0.30 |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the PolyPeptide Group AG. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the PolyPeptide Group AG was 90.10%, occurring on Jan 19, 2024. The portfolio has not yet recovered.
The current PolyPeptide Group AG drawdown is 84.65%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -90.1% | Sep 7, 2021 | 600 | Jan 19, 2024 | — | — | — |
| -11.56% | Jul 26, 2021 | 16 | Aug 16, 2021 | 2 | Aug 18, 2021 | 18 |
| -9.11% | May 7, 2021 | 15 | May 31, 2021 | 8 | Jun 10, 2021 | 23 |
| -6.68% | Jul 12, 2021 | 2 | Jul 13, 2021 | 4 | Jul 19, 2021 | 6 |
| -5.16% | Aug 23, 2021 | 2 | Aug 24, 2021 | 3 | Aug 27, 2021 | 5 |
Volatility
Volatility Chart
The current PolyPeptide Group AG volatility is 12.45%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Historical P/E Ratio Chart
The chart below displays the historical trend of the price-to-earnings (P/E) ratio for PolyPeptide Group AG.
Loading data...
Income Statement
| TTM | |
|---|---|
Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |